NasdaqGM - Nasdaq Real Time Price USD
Fulcrum Therapeutics, Inc. (FULC)
5.79
+0.11
+(1.94%)
At close: May 13 at 4:00:02 PM EDT
5.79
0.00
(0.00%)
After hours: May 13 at 7:26:07 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
7,809
-2,218
-90,965
-97,050
-78,478
Investing Cash Flow
-6,675
32,230
-36,692
12,413
-129,669
Financing Cash Flow
1,095
2,746
118,122
84,323
186,507
End Cash Position
43,379
59,413
26,655
36,190
36,504
Interest Paid Supplemental Data
--
--
--
--
0
Capital Expenditure
--
-278
-508
-1,963
-1,713
Issuance of Capital Stock
--
0
117,345
80,804
182,857
Repayment of Debt
--
--
--
0
-18
Free Cash Flow
7,559
-2,496
-91,473
-99,013
-80,191
12/31/2021 - 7/18/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ORIC ORIC Pharmaceuticals, Inc.
5.31
-1.85%
DYN Dyne Therapeutics, Inc.
12.10
-3.66%
RYTM Rhythm Pharmaceuticals, Inc.
56.79
-3.69%
TSHA Taysha Gene Therapies, Inc.
2.3400
+0.86%
DSGN Design Therapeutics, Inc.
3.5700
-1.38%
CGEM Cullinan Therapeutics, Inc.
7.62
-3.67%
SLNO Soleno Therapeutics, Inc.
74.44
-2.95%
INZY Inozyme Pharma, Inc.
1.0900
-7.63%
LXEO Lexeo Therapeutics, Inc.
2.8300
+7.60%
RZLT Rezolute, Inc.
3.6700
-1.61%